Home › Funds › ARCH Venture Management, LLC › ERAS

ARCH Venture Management, LLC position in ERAS

ERASCA INC · Health Care

ARCH Venture Management, LLC reported holding 7,091,557 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$129.9M, representing 11.81% of its reported portfolio and ranking #5 among its reported holdings. ARCH Venture Management, LLC has disclosed ERAS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)7.09M sh
Reported value held$129.92M
Portfolio Weight11.81%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ARCH Venture Management, LLC's ERAS position evolved

ARCH Venture Management, LLC first disclosed a stake in ERAS in Q3 2023 at 11,055,554 shares (US$21.8M). The position peaked in Q2 2026 at 7,091,557 shares, worth US$129.9M. Across 12 filings, ARCH Venture Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 7,091,557 shares valued at US$129.9M. Notable position changes include a 36% trim in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.06M $21.78M New
Q4 2023 11.06M $23.55M Hold
Q1 2024 11.06M $22.77M Hold
Q2 2024 11.06M $26.09M Hold
Q3 2024 11.06M $30.18M Hold
Q4 2024 11.06M $27.75M Hold
Q1 2025 11.06M $15.15M Hold
Q2 2025 11.06M $14.10M Hold
Q3 2025 11.06M $24.10M Hold
Q4 2025 11.06M $41.13M Hold
Q1 2026 7.09M $114.74M Reduce
Q2 2026 7.09M $129.92M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has ARCH Venture Management, LLC held ERAS?

ARCH Venture Management, LLC has disclosed ERAS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ARCH Venture Management, LLC's current position in ERAS?

As of Q2 2026, ARCH Venture Management, LLC holds 7.09M shares of ERAS (ERASCA INC), valued at $129.92M, representing 11.81% of its reported portfolio and ranking #5.

Has ARCH Venture Management, LLC been buying or selling ERAS?

In the latest 13F filing (Q2 2026), ARCH Venture Management, LLC held unchanged its position in ERAS. The position peaked in Q2 2026 at 7.09M shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.